ID   iMycEmu-1
AC   CVCL_0348
SY   iMycEmu1
DR   MCCL; MCC:0000498
DR   Wikidata; Q54897687
RX   PubMed=16277667;
RX   PubMed=16759389;
CC   Breed/subspecies: iMycEmu transgenic.
DI   NCIt; C21602; Mouse lymphoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 8
//
RX   PubMed=16277667; DOI=10.1186/1476-4598-4-40; PMCID=PMC1298327;
RA   Han, Seong-Su
RA   Shaffer, Arthur L. 3rd
RA   Peng, Liang-Ping
RA   Chung, Seung-Tae
RA   Lim, Jae Hwan
RA   Maeng, Sung-Ho
RA   Kim, Joong Su
RA   McNeil, Nicole E.
RA   Ried, Thomas
RA   Staudt, Louis Michael
RA   Janz, Siegfried
RT   "Molecular and cytological features of the mouse B-cell lymphoma line
RT   iMycEmu-1.";
RL   Mol. Cancer 4:40.1-40.10(2005).
//
RX   PubMed=16759389; DOI=10.1186/1476-4598-5-22; PMCID=PMC1553469;
RA   Han, Seong-Su
RA   Peng, Liang-Ping
RA   Chung, Seung-Tae
RA   DuBois, Wendy
RA   Maeng, Sung-Ho
RA   Shaffer, Arthur L. 3rd
RA   Sporn, Michael B.
RA   Janz, Siegfried
RT   "CDDO-imidazolide inhibits growth and survival of c-Myc-induced mouse
RT   B cell and plasma cell neoplasms.";
RL   Mol. Cancer 5:22.1-22.15(2006).
//